首页 | 本学科首页   官方微博 | 高级检索  
     


Higher adherence with 3‐year entecavir treatment than lamivudine or telbivudine in treatment‐naïve Taiwanese patients with chronic hepatitis B
Authors:Rong‐Nan Chien  Cheng‐Yuan Peng  Jia‐Horng Kao  Tsung‐Hui Hu  Chun‐Che Lin  Chi‐Tan Hu  Chi‐Yi Chen  Tsai‐Yuan Hsieh  Han‐Chieh Lin  Wan‐Long Chuang  Taiwan NA‐Registry Group
Affiliation:1. Liver Research Unit, Chang Gung Memorial Hospital and University, , Keelung, Taiwan;2. School of Medicine, China Medical University, , Taichung, Taiwan;3. Department of Internal Medicine, China Medical University Hospital, , Taichung, Taiwan;4. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and Hospital, , Taipei, Taiwan;5. Department of Internal Medicine, Chang Gung Memorial Hospital, , Kaohsiung, Taiwan;6. Department of Internal Medicine, Chung Shan Medical University Hospital, , Taichung, Taiwan;7. Department of Internal Medicine and Research Center for Hepatology, Buddhist Tzu Chi General Hospital, , Hualien, Taiwan;8. Internal Medical Department, Chia‐Yi Christian Hospital, , Chia‐Yi, Taiwan;9. Department of Internal Medicine, Tri‐Service General Hospital, National Defense Medical Center, , Taipei, Taiwan;10. Department of Medicine, Taipei Veterans General Hospital, , Taipei, Taiwan;11. Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, , Kaohsiung, Taiwan
Abstract:
Keywords:chronic hepatitis B  entecavir  lamivudine  patient adherence  telbivudine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号